
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Iolyx Therapeutics and Laboratoires Théa enter into agreement over ILYX-002 for the treatment of OSD
2
First patient treated in ViaLase’s IDE trial
3
PainReform launches development plan for OcuRing-K, readies phase 2 trial
4
Avisi Technologies treats first patient in SAPPHIRE trial for glaucoma
5




.png)


